10 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... Global Initiative for ... corticosteroid; FEV1 ... : forced expiratory ... #Management #Pulmonary
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... immunotherapy; FEV1 ... : forced expiratory ... #GINA #Asthma #Management ... #Stepwise #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
assessment test; FEV1 ... , forced expiratory ... corticosteroid; LABA ... #Algorithm #Management ... #Pulmonary #LABA
Cor triatriatum
 • Epidemiology
 • Etiology
 • Associated Lesions
 • Differentials Diagnosis
 • Anatomy - Sinister,
Associated Lesions • Differentials ... Diagnosis • Anatomy ... Physiology • Clinical ... Diagnosis • Treatment ... cardiology #summary #peds
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Diagnosis: • Labs ... - pulmonary opacities ... initiation • Differential ... APML #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... #diagnosis #differential ... #algorithm #management ... #table #foamed
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... - No specific lab ... Organizing Pneumonia Treatment ... #BOOP #pulmonary ... ILD #diagnosis #management
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Clinical Picture ... life-threatening Differential ... Labs: - AchR antibodies ... immunosuppressants - Meds ... Gravis #diagnosis #management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... cardiomyopathy • Pulmonary ... Clinical • Under-recognized ... patients clinically ... #cardiology #treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
disease b) CHF ... Change in clinical ... Meds: 1. ... Determine if any labs ... medical and surgical management